- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Myungmoon Pharm Co Ltd (017180)
Myungmoon Pharm Co Ltd stock price live, this page displays KS 017180 stock exchange data. View the 017180 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Myungmoon Pharm Co Ltd real time stock price chart below.
What Is the Myungmoon Pharm Co Ltd Stock Price Today?
The Myungmoon Pharm Co Ltd stock price today is 1,273.
What Is the Stock Symbol for Myungmoon Pharm Co Ltd?
The stock symbol for Myungmoon Pharm Co Ltd is "017180."
What Stock Exchange Does Myungmoon Pharm Co Ltd Trade On?
Myungmoon Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Myungmoon Pharm Co Ltd a Good Stock to Buy?
Determining whether Myungmoon Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 017180 quote. (ISIN: KR7017180001)
What Is the Myungmoon Pharm Co Ltd Stock Price Today?
The Myungmoon Pharm Co Ltd stock price today is 1,273.
What Is the Stock Symbol for Myungmoon Pharm Co Ltd?
The stock symbol for Myungmoon Pharm Co Ltd is "017180."
What Stock Exchange Does Myungmoon Pharm Co Ltd Trade On?
Myungmoon Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Myungmoon Pharm Co Ltd a Good Stock to Buy?
Determining whether Myungmoon Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 017180 quote. (ISIN: KR7017180001)
Seoul
Currency in KRW
1,273
+6(+0.47%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,258
1,276
52 wk Range
1,000
2,055
017180 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,2581,276
52 wk Range
1,0002,055
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
017180 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
-37.00 / --
Revenue / Forecast
51.21B / --
Compare 017180 to Peers and Sector
Metrics to compare | 017180 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship017180PeersSector | |
|---|---|---|---|---|
P/E Ratio | −25.5x | 1.5x | −0.3x | |
PEG Ratio | 0.11 | 0.02 | 0.00 | |
Price/Book | 0.4x | 0.5x | 2.6x | |
Price / LTM Sales | 0.2x | 0.7x | 3.0x | |
Upside (Analyst Target) | - | 53.6% | 58.6% | |
Fair Value Upside | Unlock | 32.4% | 8.4% | Unlock |
MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, antidiarrheal agents, digestive system products, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Myungmoon Pharm (017180) Stock Price Today?
The Myungmoon Pharm stock price today is 1,273 KRW.
What Stock Exchange Does Myungmoon Pharm Trade On?
Myungmoon Pharm is listed and trades on the Seoul Stock Exchange.
What Is the Stock Symbol for Myungmoon Pharm?
The stock symbol for Myungmoon Pharm is "017180."
What Is the Myungmoon Pharm Market Cap?
As of today, Myungmoon Pharm market cap is 42.55B KRW.
What Is Myungmoon Pharm's Earnings Per Share (TTM)?
The Myungmoon Pharm EPS (TTM) is -50.
From a Technical Analysis Perspective, Is 017180 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Myungmoon Pharm Stock Split?
Myungmoon Pharm has split 14 times.
How Many Employees Does Myungmoon Pharm Have?
Myungmoon Pharm has 319 employees.
What is the current trading status of Myungmoon Pharm (017180)?
As of Oct 03, 2026, Myungmoon Pharm (017180) is trading at a price of 1,273 KRW, with a previous close of 1,273 KRW. The stock has fluctuated within a day range of 1,258 KRW to 1,276 KRW, while its 52-week range spans from 1,000 KRW to 2,055 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.